Share

Latest Documents


  • 1-December-2020

    English

    Pharmaceuticals

    Pharmaceuticals have contributed to improvements in life expectancy and quality of life of many patients. Medicines can cure, relieve symptoms, delay the onset of disease and prevent complications. They often offer good value for money. However, recent trends raise a number of concerns.

    Related Documents
  • 30-November-2020

    English

    Addressing the challenges of access to medicines

    Exploring further policy options suggested in the report Pharmaceutical Innovation and access to medicines, the OECD has undertaken, with financial support from the European Commission, several projects to further identify avenues to increase pharmaceutical expenditure efficiency and better prepare to changes in the market.

    Related Documents
  • 27-November-2020

    English, PDF, 198kb

    COVID-19 OECD Health System Response Tracker

    Access our COVID-19 OECD Health System Response Tracker to learn more about the initial OECD countries' responses to the COVID-19 pandemic in 2020.

    Related Documents
  • 27-November-2020

    English

    Health at a Glance: Asia/Pacific 2020 - Measuring Progress Towards Universal Health Coverage

    This sixth edition of Health at a Glance Asia/Pacific presents a set of key indicators of health status, the determinants of health, health care resources and utilisation, health care expenditure and financing and quality of care across 27 Asia-Pacific countries and territories. It also provides a series of dashboards to compare performance across countries and territories, and a thematic analysis on the impact of the COVID-19 outbreak on Asia/Pacific health systems. Drawing on a wide range of data sources, it builds on the format used in previous editions of Health at a Glance, and gives readers a better understanding of the factors that affect the health of populations and the performance of health systems in these countries and territories. Each of the indicators is presented in a user-friendly format, consisting of charts illustrating variations across countries and territories and over time, brief descriptive analyses highlighting the major findings conveyed by the data, and a methodological box on the definition of the indicators and any limitations in data comparability. An annex provides additional information on the demographic and economic context in which health systems operate.
  • 26-November-2020

    English

    Health Expenditure

    Latest OECD figures on health spending show that health spending grew by 2.5% in 2018 with provisional estimates pointing to around 2.4% growth in 2019. OECD spending on health as a share of GDP has remained at around 8.8% on average since 2017, according to OECD Health Statistics 2020, updated in November 2020.

  • 19-November-2020

    English

    Health at a Glance: Europe 2020 - State of Health in the EU Cycle

    The 2020 edition of Health at a Glance: Europe focuses on the impact of the COVID‑19 crisis. Chapter 1 provides an initial assessment of the resilience of European health systems to the COVID-19 pandemic and their ability to contain and respond to the worst pandemic in the past century. Chapter 2 reviews the huge health and welfare burden of air pollution as another major public health issue in European countries, and highlights the need for sustained efforts to reduce air pollution to mitigate its impact on health and mortality. The five other chapters provide an overview of key indicators of health and health systems across the 27 EU member states, 5 EU candidate countries, 3 European Free Trade Association countries and the United Kingdom. Health at a Glance: Europe is the first step in the State of Health in the EU cycle.
  • 17-November-2020

    English

    Antimicrobial Resistance

    Antimicrobial resistance (AMR) is a complex issue of global concern with potentially dramatic health and economic consequences. The OECD provides a forum for discussion and provide countries with the evidence to implement effective and cost-effective policies to tackle AMR, promote effective use of antimicrobials and incentivise research and development in the antibiotic sector.

  • 20-October-2020

    English

    Health Inequalities

    Despite remarkable progress in health status and life expectancy in OECD countries over the past decades, there remain large inequalities not only across countries, but also across population groups within each country. These inequalities in health status are linked to many factors, including differences in exposure to risk factors to health and in access to health care.

  • 20-October-2020

    English

    Health Systems Characteristics

    Responses from the OECD Health System Characteristics Survey are available online, providing access to the most recent information on key institutional characteristics of health systems of OECD countries, key partner and accession countries for its 2012 and 2016 editions, as well as Latin American and Caribbean (LAC) countries for its 2018 edition.

    Related Documents
  • 20-October-2020

    English

    Paying providers for health care

    How health providers are paid is one of the key policy levers that countries have to drive health system performance. The 2012 HSC Survey analyses the payment modes currently in use in OECD countries to remunerate primary care, outpatient specialist care and inpatient care, the price regulations for health services and identifies new innovative modes of payments in more detail.

    Related Documents
  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>